Paul Symonds
Overview
Explore the profile of Paul Symonds including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
1078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguado-Barrera M, Lopez-Pleguezuelos C, Gomez-Caamano A, Calvo-Crespo P, Taboada-Valladares B, Azria D, et al.
Lung Cancer
. 2024 Dec;
199:108072.
PMID: 39740425
Background And Purpose: We investigate discrepancies in the assessment of treatment-related symptoms in lung cancer between healthcare professionals and patients, and factors contributing to these discrepancies. Materials And Methods: Data...
2.
van der Weijst L, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, et al.
Radiother Oncol
. 2022 Oct;
176:127-137.
PMID: 36195214
Background And Purpose: To investigate the association between clinician-scored toxicities and patient-reported health-related quality of life (HRQoL), in early-stage (ES-) and locally-advanced (LA-) non-small cell lung cancer (NSCLC) patients receiving...
3.
van der Weijst L, Aguado-Barrera M, Azria D, Berkovic P, Boisselier P, Briers E, et al.
Lung Cancer
. 2022 Mar;
166:228-241.
PMID: 35334417
Objectives: Radiotherapy-induced toxicity may negatively impact health-related quality of life (HRQoL). This report investigates the impact of curative-intent radiotherapy on HRQoL and toxicity in early stage and locally-advanced non-small cell...
4.
Sundar S, Symonds P
Int J Radiat Oncol Biol Phys
. 2021 Oct;
111(4):1090-1091.
PMID: 34655554
No abstract available.
5.
Sundar S, Symonds P
Int J Radiat Oncol Biol Phys
. 2021 Sep;
111(2):585.
PMID: 34473985
No abstract available.
6.
7.
8.
Polymeros K, Guttery D, Hew R, Bishop R, Stannard E, Macip S, et al.
PLoS One
. 2020 Jun;
15(6):e0233900.
PMID: 32520976
Objectives: To identify differences in the mutational profile of endometrial tumours between British White (BW) and South Asian (BSA) women. Methods: We analysed primary tumours from matched cohorts of British...
9.
Zhou C, Taylor S, Tugwood J, Simpson K, Jayson G, Symonds P, et al.
Br J Clin Pharmacol
. 2019 Apr;
85(8):1781-1789.
PMID: 30980733
Aims: There is a need for predictive and surrogate response biomarkers to support treatment with antiangiogenic vascular endothelial growth factor (VEGF) inhibitors. We aimed to identify a minimally-invasive biomarker predicting...
10.
Sternberg C, Skoneczna I, Kerst J, Albers P, Fossa S, Agerbaek M, et al.
Lancet Oncol
. 2014 Dec;
16(1):76-86.
PMID: 25498218
Background: Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to compare immediate versus deferred cisplatin-based combination chemotherapy after radical cystectomy...